GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » EPS (Diluted)

Sinopharm Tech Holdings (HKSE:08156) EPS (Diluted) : HK$-0.16 (TTM As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings EPS (Diluted)?

Sinopharm Tech Holdings's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was HK$-0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.16.

Sinopharm Tech Holdings's EPS (Basic) for the three months ended in Dec. 2023 was HK$-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.16.

Sinopharm Tech Holdings's EPS without NRI for the three months ended in Dec. 2023 was HK$-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.37.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Sinopharm Tech Holdings's highest 3-Year average EPS without NRI Growth Rate was 66.90% per year. The lowest was -240.90% per year. And the median was 6.40% per year.


Sinopharm Tech Holdings EPS (Diluted) Historical Data

The historical data trend for Sinopharm Tech Holdings's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Tech Holdings EPS (Diluted) Chart

Sinopharm Tech Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.34 -0.98 -0.62 -0.49 -0.06

Sinopharm Tech Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 -0.04 -0.11 -0.01 -

Competitive Comparison of Sinopharm Tech Holdings's EPS (Diluted)

For the Software - Application subindustry, Sinopharm Tech Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopharm Tech Holdings's PE Ratio Distribution in the Software Industry

For the Software industry and Technology sector, Sinopharm Tech Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where Sinopharm Tech Holdings's PE Ratio falls into.



Sinopharm Tech Holdings EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Sinopharm Tech Holdings's Diluted EPS for the fiscal year that ended in Jun. 2023 is calculated as

Diluted EPS (A: Jun. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-10.635-0)/182.873
=-0.06

Sinopharm Tech Holdings's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.533-0)/183.693
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinopharm Tech Holdings  (HKSE:08156) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Sinopharm Tech Holdings EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Tech Holdings (HKSE:08156) Business Description

Traded in Other Exchanges
N/A
Address
Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18/F, Ruttonjee House, Hong Kong Central, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Lottery-related services; Provision of Internet Plus services (solution and supply chain), Manufacturing and distribution of personal protective equipment, and Others services. It generates maximum revenue from the internet plus services (solution and supply chain) segment. The Internet plus Supply chain services segment includes the provision of supply chain management, data analysis and related services, and trading of goods through the internet platform. Geographically, it derives a majority of revenue from Hong Kong.
Executives
Best Frontier Investments Limited
Chan Kin Ho Philip 2201 Interest of corporation controlled by you
Lam Yui Keung 2201 Interest of corporation controlled by you
Sinopharm Traditional Chinese Medicine Overseas Holdings Limited 2101 Beneficial owner
Main Key Investments Limited 2201 Interest of corporation controlled by you
Guo Lei 2201 Interest of corporation controlled by you
Integrated Asset Management (asia) Limited 2101 Beneficial owner
Yam Tak Cheung 2201 Interest of corporation controlled by you
Chan Tung Mei 2202 Interest of your spouse
Cheung Kwai Lan 2201 Interest of corporation controlled by you
Tse Siu Hoi 2101 Beneficial owner
Gam Star China Equity (a Sub-fund Of Gam Star Fund P.l.c.) 2102 Investment manager

Sinopharm Tech Holdings (HKSE:08156) Headlines

No Headlines